The Cellular Immunotherapy for Cancer Working Committee provides scientific oversight for studies related to the utilization and outcomes after CAR-T cell therapies and other cellular immunotherapies. Studies that focus on specific outcomes, a predictor of outcomes, and utilization of CAR-T cells should be submitted to this committee.
Meetings are held annually during the Tandem Meetings | Transplantation & Cellular Therapy Meetings of ASTCT and CIBMTR. Anyone with interest or expertise in the focus area is encouraged to attend.
The TCT® Trademark belongs to the Cardiovascular Research Foundation. ASTCT, CIBMTR, MCW, NMDP, the 2019, 2020, and 2021 TCT Conferences and materials are NOT affiliated with or sponsored by Cardiovascular Research Foundation.